ReviewJournal of cancer research and clinical oncology2023

Drawbacks of immune checkpoint inhibition and rigorous management for immune-related adverse events along with a mathematical model to assess therapy success and optimum therapy duration and a strategy against tumor plasticity.

C Mehmet HendekliPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.